Vontobel Asset Management is a global multi-boutique asset manager based in Basel, Switzerland, with a history dating back to 1924. The firm specializes in various investment strategies, including Quality Growth Equities, Multi-Asset Class, Fixed Income, Global Thematic Equities, and Alternatives, operating through independent boutiques that focus on specific areas of expertise. As of mid-2018, its investment portfolio comprised 33% multi-asset, 39% equity, and 29% fixed income. Vontobel is dedicated to expanding its Fixed Income boutique globally and enhancing its presence in the UK market. Additionally, Vontobel European Ventures, a venture capital fund located in Zurich, focuses on investments in the semiconductor and technology, media, and telecommunications sectors across Europe. In 2015, Vontobel Asset Management integrated Harcourt, which specializes in alternative investments, into its broader operational framework.
Colgate-Palmolive Company is a global consumer products firm operating in over 200 countries. The company is structured into two primary segments: Oral, Personal, and Home Care, and Pet Nutrition. Its Oral Care segment features a variety of well-known toothpaste brands, such as Colgate Total and Colgate Optic White, along with toothbrushes and mouth rinses. Additionally, Colgate offers dental floss and pharmaceutical products aimed at dental professionals. The Personal Care segment includes popular brands like Palmolive and Softsoap, which encompass shower gels, bar soaps, and deodorants. Liquid hand soaps are also marketed under the Palmolive and Softsoap brands. Furthermore, Colgate-Palmolive is involved in the pet nutrition market through its Hill's Pet Nutrition segment, providing specialized products for dogs and cats.
Notenstein La Roche is a prominent Swiss private bank specializing in integrated wealth management and asset management services. With CHF 17 billion in assets under management, the bank offers personalized and comprehensive financial advice to its clients. Its services encompass investment advisory, wealth management, financial and pension planning, as well as mortgage loans and related financing solutions. A dedicated team of approximately 400 professionals operates across 13 locations, ensuring high-quality service and client satisfaction. Notenstein La Roche is supported by its parent company, Raiffeisen Switzerland, which ranks among the largest banks in the country, further enhancing its credibility and stability in the financial sector.
TwentyFour Asset Management is an independent fixed income specialist based in the City of London. Founded in 2008 by a group of leading fixed income professionals, we currently manage £4.3bn for our clients. We offer highly transparent products that benefit from a rigorous detail-oriented investment approach, in order to achieve superior risk-adjusted returns whilst retaining a strong focus on capital preservation.
Derivative.Com
Acquisition in 2014
Derivative.Com AG provides an online platform that allows asset managers, banks, pension funds and insurance companies, and other regulated investment professionals to compare pricings for customized structured products and trade in primary market in Switzerland and Liechtenstein.
Commerzbank (Switzerland) AG specializes in private banking and commercial banking services. The bank offers a range of financial products, including credit and debit cards, ATM services, securities management, loans, as well as savings and current accounts. With its focus on delivering comprehensive banking solutions, Commerzbank (Switzerland) caters to both individual and corporate clients, ensuring access to essential financial services tailored to meet their needs.
Harcourt Investment Consulting
Acquisition in 2005
Harcourt Investment Consulting provides consulting and advisory services. It provides its services to institutional clients.
EpiCept Corporation headquarters are located in Englewood Cliffs, New Jersey, with a subsidiary company, EpiCept GmbH in Munich Germany. This transatlantic presence facilitates access to European technology and markets and enhances financing and liquidity opportunities. EpiCept and its subsidiary are focused on developing novel, effective, safe and economical prescription pain products delivering drugs to a target area by using a topical delivery approach as opposed to systemic or transdermal modes. It is envisioned that EpiCept products will have significant market potential. The products are protected by an aggressive patent program.
MainControl® is a leading provider of e-Infrastructure management solutions that can help your company manage the technology infrastructure profitably and efficiently. Founded in 1994, MainControl provides more than 200 corporations worldwide with its industry-leading solutions to manage e-Infrastructure resources throughout the life cycle - from planning and procurement to deployment and disposal.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.